Home > Boards > Free Zone > User's Groups > $$$$$$$~MARIJUANA~ PLAYS~&~BIG~MOMO/PROMO PLAYS~$$$$$$$

Lexaria Biotech on the target price of $1.20

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Alexulf Member Profile
 
Followed By 9
Posts 2,312
Boards Moderated 5
Alias Born 03/20/17
160x600 placeholder
U.S. Stocks Close Higher as Investors Eye Stimulus Talks
U.S. stocks rose Thursday after economic data showed an improving economy and investors monitored negotiations in Washington over a fresh stimulus bill that could further support the recovery.
AT&T Pinched by Cord-Cutting and Closed Theaters --3rd Update
Intel Hit as Consumers Flock to Lower-Cost Laptops, Datacenter Chips
FDA Approves Gilead Sciences' Remdesivir Treatment for Covid-19
AMC Bonds Fall Despite Theater Reopenings -- Update
Goldman Seizing or Withholding $174 Million From Executives for 1MDB Case -- 4th Update
The U.S. vs. China: The High Cost of the Technology Cold War -- Journal Report
The Problem With Tech Monopolies, From Both Sides of the Political Aisle -- Journal Report
Goldman Seizing or Withholding $174 Million From Executives for 1MDB Case -- 3rd Update
Wheat Drops Amid Rain Forecasts for Major Growing Areas
Top Company News of the Day
U.S. Existing-Home Sales Rose 9.4% in September -- 2nd Update
China Economic Rebound Pushes Copper Prices to Multiyear High
Gucci Struggles as Pandemic Keeps Tourists Home
Correction to Wall Street Electric Car Article
Bayer's Request for Roundup Appeal Rejected by California Court
Goldman Seizing or Withholding $174 Million From Executives for 1MDB Case -- 2nd Update
U.S. Stocks Waver as Investors Eye Stimulus Talks
Walgreens Expands Covid-19 Testing Services to Children
ITM Power to Raise a Minimum of GBP150.0 Million
Sabre Shares Up 15% After AI Partnership With Google
Alexulf   Saturday, 09/26/20 06:58:36 AM
Re: None
Post # of 83904 
Lexaria Biotech on the target price of $1.20 per share estimated by MarketWatch.

I checked message boards on several other forums yesterday, and found that some are talking about a possible reverse split as a vehicle to a higher exchange. Remember, Lexaria said they have applied to a major exchange in the U.S.

So, let me address this issue. According to TDAmeritrade, Lexaria only has less then 90 million shares outstanding. If we assume the major American exchange is the NASDAQ, they look for liquidity as one of their criteria. So I suggest 90 million shares outstanding is barely liquid at all, and a reverse split would reduce that number dramatically. Therefore, I think we can safely discard that idea, and maybe even consider a forward split to help the liquidity issue.

So how do we meet the $4.00 dollar minimum for NASDAQ? I suggest the large orders Lexaria is likely to get from big tobacco (Altria license renewal is due on October 9th). I further suggest these large companies will actually pay for any future clinical trials because they will want to market their products as soon as possible.

All in my opinion, but some serious food for thought. See Lexaria board (canadian) for more info, thx.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences